Antimycotic azoles. 7. Synthesis and antifungal properties of a series of novel triazol-3-ones
The DOI matches its Crossref record.
Abstract
A series of novel triazol-3-ones have been synthesized, and their in vitro and in vivo antifungal properties are reported. Compound 68 (itraconazole), which displays a pronounced oral activity against vaginal candidosis in rats and against microsporosis in guinea pigs, has been selected for clinical evaluation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Still being checked.
Cited by
An overview of the key routes to the best selling 5-membered ring heterocyclic pharmaceuticals
Baumann, M., Baxendale, I. R., Ley, S. V., & Nikbin, N. (2011) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.7.57 · Cited by 605
Overview of medically important antifungal azole derivatives
Fromtling, R. A. (1988) · Clinical Microbiology Reviews · doi:10.1128/cmr.1.2.187 · Cited by 398
Antifungal agents: An overview. Part I
Gupta, A. K., Sauder, D. N., & Shear, N. H. (1994) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(08)81495-8 · Cited by 369
ROLE OF ITRACONAZOLE METABOLITES IN CYP3A4 INHIBITION
Isoherranen, N., Kunze, K. L., Allen, K. E., Nelson, W. L., & Thummel, K. E. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.000315 · Cited by 276
“N-Desalkylitraconazole was prepared from an intermediate hydrazide-carboxamide, also provided by Dr. Heeres, by reaction with formamidine acetate to generate the triazolone ring, as previously reported (Heeres et al., 1984).”
MethodAntifungal agents: An overview. Part II
Gupta, A. K., Sauder, D. N., & Shear, N. H. (1994) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(94)70112-1 · Cited by 241
Van Cutsem, J., Van Gerven, F., & Janssen, P. A. J. (1987) · Clinical Infectious Diseases · doi:10.1093/clinids/9.supplement_1.s15 · Cited by 209
Multi-azole resistance in Aspergillus fumigatus
Howard, S. J., Webster, I., Moore, C. B., Gardiner, R. E., Park, S., Perlin, D. S., & Denning, D. W. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.08.017 · Cited by 203
Itraconazole Therapy in Lymphangitic and Cutaneous Sporotrichosis
Restrepo, Á. (1986) · Archives of Dermatology · doi:10.1001/archderm.122.4.413 · Cited by 185
Posttreatment itraconazole levels in the nail
Willemsen, M., Doncker, P. D., Willems, J., Woestenborghs, R. J. H., de Velde, V. V., Heykants, J., Cutsem, J. V., Cauwenbergh, G. F. M. J., & Roseeuw, D. I. (1992) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(92)70102-l · Cited by 174
New targets and delivery systems for antifungal therapy
Walsh, T. J., Viviani, M.-A., Arathoon, E., Chiou, C., Ghannoum, M., Groll, A. H., & Odds, F. C. (2000) · Medical Mycology · doi:10.1080/mmy.38.s1.335.347 · Cited by 161
Itraconazole, a new triazole that is orally active in aspergillosis
Van Cutsem, J., Van Gerven, F., Van de Ven, M. A., Borgers, M., & Janssen, P. A. (1984) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.26.4.527 · Cited by 158
Contribution of Itraconazole Metabolites to Inhibition of CYP3A4 In Vivo
Templeton, I. E., Thummel, K. E., Kharasch, E. D., Kunze, K. L., Hoffer, C. J., Nelson, W. L., & Isoherranen, N. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100230 · Cited by 145
Heeres, J., Meerpoel, L., & Lewi, P. J. (2010) · Molecules · doi:10.3390/molecules15064129 · Cited by 142
Self-citationItraconazole: Pharmacologic Studies in Animals and Humans
Van Cauteren, H., Heykants, J., De Coster, R., & Cauwenbergh, G. (1987) · Clinical Infectious Diseases · doi:10.1093/clinids/9.supplement_1.s43 · Cited by 131
Karabasanagouda, T., Adhikari, A. V., & Shetty, N. S. (2006) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2006.10.010 · Cited by 136
An overview of azoles targeting sterol 14α-demethylase for antileishmanial therapy
Emami, S., Tavangar, P., & Keighobadi, M. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.04.044 · Cited by 131
Determination of cisapride in plasma and animal tissues by high-performance liquid chromatography
Woestenborghs, R. J. H., Lorreyne, W., Rompaey, F. V., & Heykants, J. (1988) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(00)81094-4 · Cited by 121
Drug Strategies Targeting CYP51 in Neglected Tropical Diseases
Choi, J. Y., Podust, L. M., & Roush, W. R. (2014) · Chemical Reviews · doi:10.1021/cr5003134 · Cited by 117
Determination of itraconazole in plasma and animal tissues by high-performance liquid chromatography
Woestenborghs, R. J. H., Lorreyne, W., & Heykants, J. (1987) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/0378-4347(87)80249-9 · Cited by 114
Oral carriage of candida in healthy and HIV-seropositive persons
Hauman, C. H. J., Thompson, I. O. C., Theunissen, F., & Wolfaardt, P. (1993) · Oral Surgery Oral Medicine Oral Pathology · doi:10.1016/0030-4220(93)90064-b · Cited by 99
The In‐vitro Antifungal Spectrum of Itraconazole
Cutsem, J. V. (1989) · Mycoses · doi:10.1111/j.1439-0507.1989.tb02290.x · Cited by 94
Developments in the Application of 1,2,3-Triazoles in Cancer Treatment
Slavova, K. I., Todorov, L. T., Belskaya, N. P., Palafox, M. A., & Kostova, I. P. (2020) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/1574892815666200717164457 · Cited by 93
Mechanisms of triazole resistance in Aspergillus fumigatus
Nywening, A. V., Rybak, J. M., Rogers, P. D., & Fortwendel, J. R. (2020) · Environmental Microbiology · doi:10.1111/1462-2920.15274 · Cited by 87
Nakamura, T., Sato, M., Kakinuma, H., Miyata, N., Taniguchi, K., Bando, K., Koda, A., & Kameo, K. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm020557k · Cited by 83
Efficacy of Itraconazole in the Prophylactic Treatment of Pityriasis (Tinea) Versicolor
Faergemann, J., Gupta, A. K., Mofadi, A. A., Abanami, A., Shareaah, A. A., & Marynissen, G. (2002) · Archives of Dermatology · doi:10.1001/archderm.138.1.69 · Cited by 82
CURRENT MANAGEMENT OF ONYCHOMYCOSIS
Gupta, A. K., Scher, R. K., & Doncker, P. D. (1997) · Dermatologic Clinics · doi:10.1016/s0733-8635(05)70420-4 · Cited by 82
Ferreira, V. F., da Rocha, D. R., da Silva, F. D. C., Ferreira, P. G., Boechat, N., & de Magalhães, J. L. (2013) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2013.749862 · Cited by 74
Khan, J., Rani, A., Aslam, M., Maharia, R. S., Pandey, G., & Nand, B. (2024) · Tetrahedron · doi:10.1016/j.tet.2024.134122 · Cited by 73
Drug Syntheses Beyond the Rule of 5
Tyagi, M., Begnini, F., Poongavanam, V., Doak, B. C., & Kihlberg, J. O. (2019) · Chemistry - A European Journal · doi:10.1002/chem.201902716 · Cited by 63
Bourlond, A., Lachapelle, J., Aussems, J., Boyden, B., Campaert, H., Conincx, S., Decroix, J., Geeraerts, C., Ghekiere, L., Porters, J. E., et al. (1989) · International Journal of Dermatology · doi:10.1111/j.1365-4362.1989.tb02491.x · Cited by 62
STEREOCHEMICAL ASPECTS OF ITRACONAZOLE METABOLISM IN VITRO AND IN VIVO
Kunze, K. L., Nelson, W. L., Kharasch, E. D., Thummel, K. E., & Isoherranen, N. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.008508 · Cited by 61
Pace, J. R., DeBerardinis, A. M., Sail, V., Tacheva-Grigorova, S. K., Chan, K. A., Tran, R., Raccuia, D. S., Wechsler-Reya, R. J., & Hadden, M. K. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01718 · Cited by 60
Jacobsen, C. B., Meldal, M., & Diness, F. (2016) · Chemistry - A European Journal · doi:10.1002/chem.201604098 · Cited by 56
Cutsem, J. V. (1989) · Mycoses · doi:10.1111/j.1439-0507.1989.tb02291.x · Cited by 56
Shi, W., Nacev, B. A., Aftab, B. T., Head, S., Rudin, C. M., & Liu, J. O. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200944b · Cited by 45
Itraconazole: an effective oral antifungal for onychomycosis
Jain, S., & Sehgal, V. N. (2001) · International Journal of Dermatology · doi:10.1046/j.1365-4362.2001.01039.x · Cited by 55
Recent advances of RAF (rapidly accelerated fibrosarcoma) inhibitors as anti-cancer agents
Ammar, U. M., Abdel‐Maksoud, M. S., & Oh, C. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.09.005 · Cited by 54
Treatment of human cutaneous sporotrichosis with itraconazole
Díaz, I. A. C., Civila, E., Gezuele, E., Lowinger, M., Calegari, L., Sanabria, D., Fuentes, L., da Rosa, D., & Alzueta, G. A. (1992) · Mycoses · doi:10.1111/j.1439-0507.1992.tb00836.x · Cited by 52
Schaude, M., Ackerbauer, H., & Mieth, H. (1987) · Mycoses · doi:10.1111/j.1439-0507.1987.tb03980.x · Cited by 52
Du, S., Wang, W., Song, Y., Chen, Z., & Wu, X. (2021) · Organic Letters · doi:10.1021/acs.orglett.0c04167 · Cited by 47
In Vitro Susceptibilities of Isolates of Sporothrix schenckii to Itraconazole and Terbinafine
Kohler, L. M., Monteiro, P. C. F., Hahn, R. C., & Hamdan, J. S. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.9.4319-4320.2004 · Cited by 47
Impact of Absolute Stereochemistry on the Antiangiogenic and Antifungal Activities of Itraconazole
Shi, W., Nacev, B. A., Bhat, S., & Liu, J. O. (2010) · ACS Medicinal Chemistry Letters · doi:10.1021/ml1000068 · Cited by 46
Cutsem, J. V., Gerven, F. V., & Janssen, P. A. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.12.2063 · Cited by 43
Ghanaat, J., Khalilzadeh, M. A., & Zareyee, D. (2020) · Molecular Diversity · doi:10.1007/s11030-020-10050-0 · Cited by 41
Itraconazole treatment of murine aspergillosis
Graybill, J. R., & Ahrens, J. (1985) · Medical Mycology · doi:10.1080/00362178585380321 · Cited by 38
Panagiotidou, D., Kousidou, T., Chaidemenos, G., Karakatsanis, G., Kalogeropoulou, A., Teknetzis, A., Chatzopoulou, E., & MICHAILIDIS, D. (1992) · Journal of International Medical Research · doi:10.1177/030006059202000504 · Cited by 37
Qin, M., Zhai, X., Xie, H., Ma, J., Lu, K., Wang, Y. C., Wang, L., Gu, Y., & Gong, P. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.04.059 · Cited by 37
Thienpont, A., Gal, J., Aeschlimann, C., & Félix, G. (1999) · Analusis · doi:10.1051/analusis:1999270713 · Cited by 37
Leaver, D. J. (2018) · Molecules · doi:10.3390/molecules23071753 · Cited by 36
Ultrastructural Correlates of Antimycotic Treatment
Borgers, Μ. (1988) · Current topics in medical mycology · doi:10.1007/978-1-4612-3730-3_1 · Cited by 35
Du, S., Yang, Z., Tang, J., Chen, Z., & Wu, X. (2021) · Organic Letters · doi:10.1021/acs.orglett.1c00568 · Cited by 34
Synthesis and Biological Activities of Some 3,6-Disubstituted ThiazoIo[3,2-b][1,2,4] triazoIes
EROL, D. D., Çalış, Ü., Demirdamar, R., Yuluğ, N., & Ertan, M. (1995) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600840414 · Cited by 34
Hecke, E. V., & Cutsem, J. V. (1988) · Mycoses · doi:10.1111/j.1439-0507.1988.tb04419.x · Cited by 34
Moossavi, M., Bagheri, B., & Scher, R. K. (2001) · Dermatologic Clinics · doi:10.1016/s0733-8635(05)70228-x · Cited by 33
Hepperle, M. E., Eckert, J., Gala, D., Shen, L., Evans, C. A., & Goodman, A. (2002) · Tetrahedron Letters · doi:10.1016/s0040-4039(02)00556-7 · Cited by 33
Pityriasis versicolor: a review of pharmacological treatment options
Gupta, A. K., Kogan, N., & Batra, R. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.2.165 · Cited by 32
Pyrrolo[1,2-a][1,4]benzodiazepine: A novel class of non-azole anti-dermatophyte anti-fungal agents
Meerpoel, L., Gestel, J. V., Gerven, F. V., Woestenborghs, F., Marichal, P., Sipido, V., Terence, G., Nash, R., Corens, D., & Richards, R. D. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.05.007 · Cited by 32
Saksena, A. K., GIRIJAVALLABHAN, V. M., Lovey, R. G., Pike, R. E., Desai, J. A., Ganguly, A. K., Hare, R. S., Loebenberg, D., Cacciapuoti, A. F., & Parmegiani, R. M. (1994) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)80556-4 · Cited by 29
Hepperle, M. E., Eckert, J., & Gala, D. (1999) · Tetrahedron Letters · doi:10.1016/s0040-4039(99)01103-x · Cited by 29
Meerpoel, L., Backx, L. J. J., der Veken, L. J. E. V., Heeres, J., Corens, D., Groot, A. D., Odds, F. C., Gerven, F. V., Woestenborghs, F., Breda, A. V., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0494772 · Cited by 29
Self-citationItraconazole in the treatment of superficial mycoses-a double-blind study vs. placebo
Roseeuw, D. I., WILLEMSEN, M., KINT, R. T., Peremans, W., Mertens, R. L. J., & Cutsem, J. V. (1990) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.1990.tb02041.x · Cited by 29
Niwano, Y., Kuzuhara, N., Goto, Y., Munechika, Y., Kodama, H., Kanai, K., Yoshida, M., Miyazaki, T., & Yamaguchi, H. (1999) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(99)00076-x · Cited by 28
Liu, Y., Liu, Z., Cao, X., Liu, X., He, H., & Yang, Y. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.06.062 · Cited by 28
Fesenko, A. A., & Shutalev, A. D. (2015) · Tetrahedron · doi:10.1016/j.tet.2015.10.079 · Cited by 25
Synthesis and bioassay of a new class of heterocycles pyrrolyl oxadiazoles/thiadiazoles/triazoles
Padmavathi, V., Mohan, A. V. N., Thriveni, P., & Shazia, A. (2008) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2008.04.003 · Cited by 25
Antifungal and Immunomodulating Activities of 1,4-Benzothiazine Azole Derivatives: Review
Schiaffella, R. F., & Vecchiarelli, A. (2001) · Journal of Chemotherapy · doi:10.1179/joc.2001.13.1.9 · Cited by 24
Ma, W. B., Li, S. N., Zhou, Z., Shen, H. S., Li, X., Sun, Q., He, L., & Xue, Y. W. (2012) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201101463 · Cited by 23
Bernal, J. L., Toribio, L., Nozal, M. J., Nieto, E. M., & Jiménez, J. J. (2000) · Journal of Chromatography A · doi:10.1016/s0021-9673(99)00856-0 · Cited by 23
Candidiasis Endocrinopathy Syndrome: Treatment With Itraconazole
DePadova-Elder, S. M., Ditre, C. M., Kantor, G. R., & Koblenzer, P. J. (1994) · Archives of Dermatology · doi:10.1001/archderm.1994.01690010023002 · Cited by 23
Synthesis and biological evaluation of some novel triazol-3-ones as antimicrobial agents
Pardeshi, S. P., & Bobade, V. D. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.08.049 · Cited by 21
Bell, A. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00216-9 · Cited by 21
Vago, T., Baldi, G., Colombo, D., Barbareschi, M., Norbiato, G., Dallegri, F., & Bevilacqua, M. T. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.11.2605 · Cited by 21
Itraconazole versus ketoconazole in the treatment of tinea versicolor
Shemer, A., Nathansohn, N., Kaplan, B., & Trau, H. (1999) · Journal of Dermatological Treatment · doi:10.3109/09546639909055906 · Cited by 21
Palmer, G. C., Ordy, M., Simmons, R. D., Strand, J. C., Radov, L. A., MULLEN, G. B., Kinsolving, C. R., Georgiev, V. S., MITCHELL, J. T., & Allen, S. D. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.6.895 · Cited by 21
TINEA PEDIS (MOCASSINTYPE) TREATED WITH ITRACONAZOLE
Decroix, J. (1995) · International Journal of Dermatology · doi:10.1111/j.1365-4362.1995.tb03596.x · Cited by 21
The Base‐Promoted Annulation of 2‐Hydrazinyl Pyridine and CO2 toward Triazolones
Wu, X., Sun, S., Wang, B., & Cheng, J. (2017) · Advanced Synthesis & Catalysis · doi:10.1002/adsc.201700869 · Cited by 19
Sterol Biosynthesis Inhibiting Triazole Fungicides
Worthington, P. A. (2012) · Wiley eBooks · doi:10.1002/9783527664412.ch11 · Cited by 19
NEWER SYSTEMIC ANTIFUNGAL DRUGS FOR THE TREATMENT OF ONYCHOMYCOSIS
Chiritescu, M. M., Chiritescu, M.-E. S., & Scher, R. K. (1996) · Clinics in Podiatric Medicine and Surgery · doi:10.1016/s0891-8422(23)00838-8 · Cited by 19
Rad, M. N. S., Asrari, Z., Behrouz, S., HAKIMELAHI, G. H., & Khalafi‐Nezhad, A. (2011) · Helvetica Chimica Acta · doi:10.1002/hlca.201100189 · Cited by 18
A novel and efficient synthesis of 2,5-substituted 1,2,4-triazol-3-ones
Deng, J. Z., & Burgey, C. S. (2005) · Tetrahedron Letters · doi:10.1016/j.tetlet.2005.09.073 · Cited by 18
Randomized Comparative Trial of Three Regimens of Itraconazole for Treatment of Vaginal Mycoses
Sanz, F. S., & Hernanz, A. D. P. (1987) · Clinical Infectious Diseases · doi:10.1093/clinids/9.supplement_1.s139 · Cited by 18
Saksena, A. K., GIRIJAVALLABHAN, V. M., Lovey, R. G., Desai, J. A., Pike, R. E., Jao, E., Wang, H., Ganguly, A. K., Loebenberg, D., Hare, R. S., et al. (1995) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/0960-894x(94)00471-q · Cited by 17
Synthesis of novel 14-membered cyclic bis-semicarbazones
Shutalev, A. D., Fesenko, A. A., Kuzmina, O. M., Volov, A. N., Albov, D. V., Chernyshev, V. V., & Zamilatskov, I. A. (2014) · Tetrahedron Letters · doi:10.1016/j.tetlet.2014.08.016 · Cited by 16
The citron homology domain as a scaffold for Rho1 signaling
Bartual, S. G., Wei, W., Zhou, Y., Pravatà, V. M., Fang, W., Yan, K., Ferenbach, A. T., Lockhart, D. E. A., & van Aalten, D. M. F. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2110298118 · Cited by 15
Power, E. C., Ganellin, C. R., & Benton, D. C. H. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.11.001 · Cited by 15
Role of Animal and Human Pharmacology in Antifungal Drug Design
Cauwenbergh, G. F. M. J., & Cutsem, J. V. (1988) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1988.tb40412.x · Cited by 15
Richardson, K., & Marriott, M. S. (1987) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(08)61164-1 · Cited by 15
Štěpánek, O., Čmoková, A., Procházková, E., Grobárová, V., Černý, J., Slapničková, M., Zíková, A., Kolařík, M., & Baszczyňski, O. (2022) · ChemMedChem · doi:10.1002/cmdc.202200385 · Cited by 14
Itraconazole: Comprehensive Profile
Al‐Badr, A. A., & El‐Subbagh, H. I. (2009) · Profiles of drug substances, excipients, and related methodology · doi:10.1016/s1871-5125(09)34005-4 · Cited by 14
Shaffer, J. P., Barson, W. J., Luquette, M. H., Groner, J. I., Hogan, M. J., & Allen, E. D. (1997) · Pediatric Pulmonology · doi:10.1002/(sici)1099-0496(199707)24:1<57::aid-ppul10>3.0.co;2-9 · Cited by 14
The in vivo antifungal activity of broad‐spectrum azoles
Cutsem, J. V., & Gerven, F. V. (1986) · Drug Development Research · doi:10.1002/ddr.430080135 · Cited by 14
Fotouhi, L., Tammari, E., Asadi, S., Heravi, M. M., & Nematollahi, D. (2009) · International Journal of Chemical Kinetics · doi:10.1002/kin.20402 · Cited by 13
Preclinical antimycotic activity of SDZ 89–485: a new orally and topically effective triazole
Schaude, M., Petranyi, G., Ackerbauer, H., Meingassner, J. G., & Mieth, H. (1990) · Medical Mycology · doi:10.1080/02681219080000561 · Cited by 13
Therapy of experimental meningeal and disseminated cryptococcosis
Cutsem, J. V. (1993) · Mycoses · doi:10.1111/j.1439-0507.1993.tb00723.x · Cited by 12
Antifungal Drug Susceptibility Testing
Warnock, D. W. (1989) · Current topics in medical mycology · doi:10.1007/978-1-4612-3624-5_12 · Cited by 12
Pace, J. R., Teske, K. A., Chau, L. Q., Dash, R. C., Zaino, A. M., Wechsler‐Reya, R. J., & Hadden, M. K. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01283 · Cited by 11
Synthesis and antifungal activity of the 2,2,5-tetrahydrofuran regioisomers of SCH 51048
Lovey, R. G., Saksena, A. K., GIRIJAVALLABHAN, V. M., Blundell, P., Guzik, H. S., Loebenberg, D., Parmegiani, R. M., & Cacciapuoti, A. F. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00282-2 · Cited by 11
Prophylaxis of Candida and Aspergillus infections with oral administration of itraconazole
Cutsem, J. V. (1994) · Mycoses · doi:10.1111/j.1439-0507.1994.tb00420.x · Cited by 10
Fotouhi, L., Kiani, S. T., Nematollahi, D., & Heravi, M. M. (2007) · International Journal of Chemical Kinetics · doi:10.1002/kin.20246 · Cited by 9
Synthesis of Antifungal Imidazoles and Triazoles
Ogata, M. (1988) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1988.tb40386.x · Cited by 9
Metadata
- Authors
- Heeres, J., Backx, L. J. J., & Van Cutsem, J.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1984-07
- Volume
- 27
- Issue
- 7
- Pages
- 894-900
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W1998436712
- Cited by
- 143
- References
- 0
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 1 · 2022: 3 · 2021: 3 · 2020: 4 · 2019: 3 · 2018: 3 · 2017: 3 · 2016: 3 · 2015: 1 · 2014: 6 · 2013: 1 · 2012: 2
- FWCI
- 6.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Physical Sciences › Chemistry › Organic Chemistry › Synthesis and Characterization of Heterocyclic Compounds
- Physical Sciences › Chemistry › Organic Chemistry › Structural and Chemical Analysis of Organic and Inorganic Compounds
- Keywords
- azoles, itraconazole, antifungal agents, vaginal candidiasis
- MeSH terms
- Animals, Antifungal Agents, Aspergillus fumigatus, Candida, Candidiasis, Vulvovaginal, Cryptococcus neoformans, Dermatomycoses, Female, Guinea Pigs, Ketoconazole, Microsporum, Phialophora, Rats, Inbred Strains, Sporothrix, Triazoles, Trichophyton, Itraconazole, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.